Stockscreener 앱 받기
8.245
1.08%
-0.055
시간 외 거래:
8.24
-0.005
-0.06%
전일 마감가:
$8.30
열려 있는:
$8.3
하루 거래량:
404.34K
Relative Volume:
1.03
시가총액:
$2.59B
수익:
$391.87M
순이익/손실:
$-441.45M
주가수익비율:
-4.4568
EPS:
-1.85
순현금흐름:
$-301.21M
1주 성능:
-1.32%
1개월 성능:
+2.24%
6개월 성능:
+0.12%
1년 성능:
-36.11%
1일 변동 폭
$7.97
$8.30
1주일 범위
$7.97
$8.96
52주 변동 폭
$7.35
$13.70
Alvotech Stock (ALVO) Company Profile
ALVO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
8.25 | 2.59B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
141.09 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
439.99 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-23 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-02-14 | 개시 | UBS | Buy |
| 2024-01-29 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-09-21 | 개시 | Barclays | Equal Weight |
| 2022-09-07 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-09-06 | 다운그레이드 | Citigroup | Buy → Sell |
| 2022-07-26 | 개시 | Citigroup | Buy |
모두보기
Alvotech 주식(ALVO)의 최신 뉴스
Volume spikes in Alvotech stock – what they meanWeekly Volume Report & Safe Capital Growth Trade Ideas - newser.com
Statistical indicators supporting Alvotech Equity Warrant’s strengthPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com
How to read the order book for AlvotechJuly 2025 Price Swings & Capital Protection Trading Alerts - newser.com
Using Ichimoku Cloud for Alvotech technicalsCPI Data & Stock Market Timing Techniques - newser.com
Analyzing Alvotech with risk reward ratio chartsJuly 2025 Reactions & Free Daily Entry Point Trade Alerts - newser.com
Will Alvotech (Z45) stock beat revenue estimatesJuly 2025 Highlights & Growth Oriented Trade Recommendations - newser.com
Will Alvotech Equity Warrant stock benefit from green energy trendsJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com
News impact scoring models applied to Alvotech Equity Warrant2025 Major Catalysts & Entry Point Confirmation Signals - newser.com
Alvotech Equity Warrant stock trend outlook and recovery path2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com
Comparing Alvotech Equity Warrant in custom built stock radarsM&A Rumor & Technical Pattern Based Signals - newser.com
What does recent volatility data suggest for AlvotechJuly 2025 Fed Impact & AI Based Buy and Sell Signals - newser.com
Alvotech's (ALVO) Sell (E+) Rating Reiterated at Weiss Ratings - MarketBeat
Here's How Alvotech is Expanding its Portfolio Beyond Immunology - MSN
Alvotech And Advanz Celebrate EU Omalizumab Filing - insights.citeline.com
My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha
Alvotech’s AVT23 Biosimilar Gains EMA Acceptance - TipRanks
ALVO: EMA Begins Review of AVT23; Advanz Holds Commercial Rights - Stock Titan
Will Alvotech Equity Warrant stock recover after recent dropBuy Signal & Momentum Based Trading Ideas - newser.com
EMA accepts application for Alvotech's AVT23 - Biostock
Advanz Pharma and Alvotech Announce EMA Acceptance of Marketing Application for Biosimilar AVT23 to Xolair® - Quiver Quantitative
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency - Yahoo
Real time breakdown of Alvotech Equity Warrant stock performanceQuarterly Profit Report & Daily Profit Focused Screening - newser.com
EMA Recommendations for AVT03 and Gobivaz Could Be a Game Changer for Alvotech (ALVO) - simplywall.st
Will Alvotech benefit from macro trendsTrade Exit Report & Verified Short-Term Trading Plans - newser.com
Visual analytics tools that track Alvotech performanceJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Can Alvotech Equity Warrant recover in the next quarterPortfolio Risk Report & Reliable Entry Point Alerts - newser.com
A Fresh Look at Alvotech (NasdaqGM:ALVO) Valuation as Investors Weigh Biotech Prospects - simplywall.st
A Fresh Look at Alvotech (NasdaqGM:ALVO) Valuation After Recent Stock Uptick - Yahoo Finance
Alvotech (NasdaqGM:ALVO): Is the Market Overlooking Its True Value? - simplywall.st
Is Alvotech (Z45) stock a safe buy pre earningsEarnings Recap Report & Accurate Technical Buy Alerts - newser.com
How supply chain issues affect Alvotech Equity Warrant stockEarnings Summary Report & Expert Curated Trade Setup Alerts - newser.com
Alvotech Equity Warrant stock trendline breakdownJuly 2025 Action & Verified Entry Point Detection - newser.com
Why ETFs are accumulating Alvotech (Z45) stockQuarterly Portfolio Summary & Target Return Focused Picks - newser.com
How Alvotech Equity Warrant stock performs in high volatility markets2025 Growth vs Value & Long-Term Growth Plans - newser.com
Is Alvotech Equity Warrant stock vulnerable to regulatory risksJuly 2025 Opening Moves & AI Based Buy/Sell Signal Reports - newser.com
What candlestick patterns are forming on Alvotech Equity WarrantQuarterly Market Review & Real-Time Sentiment Analysis - newser.com
Is Alvotech Equity Warrant stock supported by innovation pipelineJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
Volume spikes in Alvotech Equity Warrant stock – what they meanRecession Risk & Safe Entry Point Identification - newser.com
Will Alvotech stock outperform tech sector in 2025July 2025 Earnings & Smart Investment Allocation Insights - newser.com
Alvotech (ALVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.54%
1.16%
자본화:
|
볼륨(24시간):